Lloyd Ratner, MD
Transplant Surgery · New York, NYNPI 1437190089
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $26,815 of the $31,911 with a category attached, or 84.0%. Sanofi-aventis U.S. LLC accounts for 67.9% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $12,822, more than ten times the $315 reported in 2019. Among transplant surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $839.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$22K
- E.r. Squibb & Sons, L.L.C.$5K
- Immucor, Inc.$3K
- Intuitive Surgical$2K
- Veloxis Pharmaceuticals, Inc.$389
- CSL Behring$161
- plus $252 from 6 others
Across 55 payments — averaging $11,150 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$484K
- Medtronic$105K
- Shire North American Group Inc$24K
What the payments were for
- Consulting fees$26,81584%
- Travel & lodging$1,8936%
- Food & beverage$1,6315%
- Education$720%
- Other$1,5005%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 9 | $21,664 |
| E.r. Squibb & Sons, L.L.C. | 11 | $4,685 |
| Immucor, Inc. | 1 | $2,975 |
| Intuitive Surgical | 3 | $1,784 |
| Veloxis Pharmaceuticals, Inc. | 6 | $389 |
| CSL Behring | 1 | $161 |
| Mallinckrodt Enterprises LLC | 1 | $72 |
| Kamada Ltd. | 2 | $47 |
| Covidien LP | 1 | $42 |
| Johnson & Johnson | 1 | $41 |
| Scpharmaceuticals Inc. | 1 | $36 |
| Conmed Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THYMOGLOBULIN$8,863
- DAVINCI XI$1,500
- Da Vinci Surgical System$284
- Haegarda$161
- Envarsus$147
How this compares
$31,911 in reported general payments places this provider in the 90th percentile of 72 transplant surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in New York
- Kishore IyerNew York$95K
- Jason HawksworthNew York$91K
- Parissa TabrizianNew York$74K
- Hautien LiouNew York$31K
- Karim HalazunNew York$28K
- Myron SchwartzNew York$27K
- Ron ShapiroNew York$16K
- Gabriel GondolesiNew York$15K
- Lewis TepermanNew York$13K
- Babak OrandiNew York$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.